Liver Disease
Conference Coverage
Statins in NAFLD: Taking a closer look at benefits
Statins could have multiple benefits in NAFLD, but there has been little insight into how they may be exerting such effects.
Conference Coverage
Phase 3 data shows bulevirtide benefit in hepatitis D
“For us in the hepatitis D field, it is a really exciting time; it’s completely novel data and game-changing for patients.”
Conference Coverage
Low-carb, high-fat diet improves A1c, reduces liver fat
Experts update the latest case numbers for acute hepatitis in children and discuss possible factors that result in the disease.
Latest News
Acute hepatitis cases in children show declining trend; adenovirus, COVID-19 remain key leads
Adenovirus remains the most commonly detected virus in acute hepatitis in children, found in 53% of cases overall.
Latest News
Pemvidutide promising for fatty liver disease
Weight loss and multiple improvements in lipid parameters linked to nonalcoholic fatty liver disease were seen in a phase 1 trial.
Conference Coverage
Fatty liver disease drives rise in liver cancer deaths
The steep increase in liver cancer deaths is due to the rising rate of NAFLD and mostly driven by the obesity and type 2 diabetes epidemics.
Conference Coverage
Novel liver-targeting drug offers hope for AAT deficiency
The investigational drug fazirsiran improved important liver parameters associated with alpha-1-antitrypsin deficiency.
From the Journals
Are pain meds the only option for chronic pain in cirrhosis?
An emphasis on nonpharmacologic approaches, such as diet and psychological interventions, can sometimes handle even less familiar sources of pain...
From the Journals
Liver-related telehealth faces tech barriers
Rural and underserved areas may lack the technology needed to access innovative care solutions.
Conference Coverage
PI-based DAAs appear safe in decompensated patients
Study shows similar tolerability with PI- and non-PI based therapies, but questions remain for Child-Pugh Score B and C.